ReDirection - Self Help Program for Individuals with Sexual Interest in Children
Launched by KAROLINSKA INSTITUTET · Nov 13, 2023
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
The ReDirection trial is a study aimed at helping individuals who have concerns about their sexual interests in children. The main goal is to see if the ReDirection program can effectively and safely reduce these individuals' use of child sexual abuse material (CSAM) and related behaviors. This program is specifically designed for those who are considered to have a low to medium risk of committing child sexual abuse.
To be eligible for this trial, participants should be between the ages of 18 and 74 and must speak one of the following languages: English, Swedish, Finnish, Czech, Slovak, German, or Spanish. They should have a genuine concern about their sexual interests regarding children and have used CSAM in the past six months. However, individuals with severe psychiatric issues or those who are not fully committed to participating in the study will not be accepted. Participants can expect a supportive environment where they will receive guidance through the ReDirection program, helping them manage their feelings and behaviors in a safe and constructive way.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Sufficient language skills: English, Swedish, Finnish, Czech, Slovak, German, or Spanish
- • concern about sexual interest regarding children\*,
- • CSAM use past six month
- • Low to medium risk for committing child sexual abuse according to the SChiMRA scale
- Exclusion Criteria:
- • - Participants with a severe psychiatric illness (such as high acute suicide risk or severe substance abuse) will be excluded, or lack of serious intentions to participate.
About Karolinska Institutet
Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Klecany, , Czechia
Helsinki, , Finland
Hamburg, , Germany
Bratislava, , Slovakia
Castelló, , Spain
Stockholm, , Sweden
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported